Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The American Journal of Ophthalmology Reckons With "Race" and "Ethnicity".

American journal of ophthalmology·2026

Same author

Analysis of capivasertib via ion-pairing with erythrocin B as a spectrofluorometric probe.

Scientific reports·2026

Same author

Phenylpiperazine/dithioates as novel H<sub>2</sub>S donors: design, synthesis, H<sub>2</sub>S release, formulation as PEG-niosomes and antifungal activity against Candida albicans.

Bioorganic chemistry·2026

Same author

Surgical outcomes of intermittent and constant exotropia in an adult population between 18 and 60 years old.

The British journal of ophthalmology·2026

Same author

The AJO and Academic Freedom: Then and Now.

American journal of ophthalmology·2025

Same author

First Fluorescence Method for Native Quantification of Pirtobrutinib Used for Treatment of Cancer in its Market Form and Biological Fluids; Application of Greenness.

Journal of fluorescence·2025

Search research articles

Related Experiment Video

Updated: May 11, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Diplopia after glaucoma drainage device implantation.

Amany Abdelaziz¹, Hilda Capó, Michael R Banitt

¹Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA.

Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus

|April 30, 2013

Summary

The incidence of diplopia after glaucoma drainage device (GDD) surgery is low, with a 1-year cumulative rate of 1.4%. Most cases of double vision following GDD implantation are effectively managed with prism correction.

More Related Videos

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Related Experiment Videos

Last Updated: May 11, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Area of Science:

Ophthalmology
Surgical Outcomes
Glaucoma Management

Background:

Glaucoma drainage devices (GDDs) are implanted to manage intraocular pressure.
Diplopia, or double vision, is a potential complication following ocular surgery.
Understanding the incidence and management of diplopia after GDD surgery is crucial for patient care.

Purpose of the Study:

To determine the incidence of diplopia after glaucoma drainage device (GDD) surgery.
To report on the treatment outcomes for patients experiencing diplopia post-GDD implantation.

Main Methods:

Retrospective review of financial claims and medical records for patients undergoing GDD surgery (CPT 66180) between 1991 and 2005.
Identification of patients diagnosed with diplopia (ICD-9 368.2) or undergoing extraocular muscle surgery (CPT-4 67311-67335) post-GDD.
Exclusion of cases with pre-existing diplopia or diplopia from other causes.

Main Results:

A total of 2,661 patients underwent GDD surgery; 32 developed secondary diplopia.
The 1-year cumulative incidence of diplopia was 1.4%, with no new cases after one year.
Diplopia onset averaged 66 days post-surgery; treatment included prisms (53.1%), no treatment (40.6%), and surgery in 9.4% of cases.

Conclusions:

The incidence of diplopia following glaucoma drainage device surgery is low.
Prism correction is the primary treatment modality for post-GDD diplopia.
Most patients experiencing diplopia after GDD surgery can be managed non-surgically.